OSLO, NORWAY - 17 AUGUST 2023 - Circa Group AS (stock symbol: CIRCA) announced
its second quarter results today. A webinar will be held at 08.30 CET (details
below).

Q2 has seen considerable progress including further optimisation of the existing
FC5 plant in Tasmania, engineering work on the ReSoluteTM plant which is due to
be commissioned in Q3 2024 and in parallel, optimisation of the future FC6
plant.

In addition, Circa filed patents for two new solvents, Furatech:1 and
Furatech:2. These new solvents have been designed for use in CO2 capture
processes where they can replace existing solvents in a number of processes. CO2
capture is a growing market as multiple solutions are required for the climate
crisis.

We announced two significant appointments - Dr Steve Döring will join Circa as
CEO in Q4 2023. Steve Döring is a chemical industry professional and experienced
CEO based in Germany with a broad background from a career with multiple roles
in larger global companies as well as leading smaller companies through
development, growth and exit.

Dr Alessandro Napoli will join Circa in Q3 2023 as VP Product Development.
Alessandro has had a long career with a major global specialty materials company
in Europe. He brings to Circa high-level R&D capabilities and a 15-year
involvement in bringing new products to market.

Circa Group AS CEO Tony Duncan said, "Circa's story since the IPO two years ago
is one of consistent optimisation and de-risking of the investment. We have
continued to develop our internal capabilities, hiring key industry experts into
key positions and we are working diligently with our engineering partners on the
next plants - ReSoluteTM and FC6. At the same time, we see that the commercial
and regulatory environments are more supportive than ever. 

Going forward, the Company will initiate discussions with industrial, strategic
and financial partners to accelerate the process and initiation related to the
FC6 project and to enhance the longer-term liquidity of the Company. The Company
and the Board of Circa have now engaged DNB Markets, a part of DNB Banks ASA and
Pareto Securities AS (together the "Managers") as financial advisors to assist
in evaluating the best strategic and financial options, including potential
partnerships for the Company in relation to the Company's current project
pipeline.

For further information, access the complete Q2 report:
https://circa-group.com/stock-announcements.

Circa Group is pleased to invite you to a presentation of their Q2 2023 Results
and a Capital Market Update. The presentation will be held physically at Pareto
Securities' offices at Dronning Mauds gate 3, Oslo. The presentation will also
be live-streamed, and questions may be submitted during the presentation. 

Click on the link in the enclosed press release to register



About Circa
Established in 2006, Circa Group converts sustainable, non-food biomass into
advanced bio-based chemicals with its proprietary FuracellTM process. Its
developing product portfolio includes flavours, biopolymers, and bio-solvents
including CyreneTM. By creating renewable chemicals from cellulose, Circa is
extracting value from non-food biomass and addressing a gap in the market by
providing bio-based, less carbon intensive alternatives, contributing to a more
circular economy.
https://circa-group.com  


Investor Contact 
Tone Leivestad
Chief Financial Officer
Circa Group AS
tone.leivestad@circa-group.com
Tel: +47 406 39 455

Media Contact 
Kathryn Sheridan
Sustainability Consult
ks@sustainabilityconsult.com